706 related articles for article (PubMed ID: 31070059)
41. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
Carroll VA; Ashcroft M
Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
[TBL] [Abstract][Full Text] [Related]
42. Targeting hypoxia for sensitization of tumors to radio- and chemotherapy.
Ghattass K; Assah R; El-Sabban M; Gali-Muhtasib H
Curr Cancer Drug Targets; 2013 Jul; 13(6):670-85. PubMed ID: 23687923
[TBL] [Abstract][Full Text] [Related]
43. Small molecules targeting HIF-1α pathway for cancer therapy in recent years.
Tang W; Zhao G
Bioorg Med Chem; 2020 Jan; 28(2):115235. PubMed ID: 31843464
[TBL] [Abstract][Full Text] [Related]
44. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
45. Pharmacologic Targeting of Hypoxia-Inducible Factors.
Semenza GL
Annu Rev Pharmacol Toxicol; 2019 Jan; 59():379-403. PubMed ID: 30625281
[TBL] [Abstract][Full Text] [Related]
46. HIF-1 inhibitors for cancer therapy: from gene expression to drug discovery.
Semenza GL
Curr Pharm Des; 2009; 15(33):3839-43. PubMed ID: 19671047
[TBL] [Abstract][Full Text] [Related]
47. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
Lim CS; Kiriakidis S; Paleolog EM; Davies AH
J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
[TBL] [Abstract][Full Text] [Related]
48. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
Martínez-Sánchez G; Giuliani A
J Exp Clin Cancer Res; 2007 Mar; 26(1):39-50. PubMed ID: 17550131
[TBL] [Abstract][Full Text] [Related]
49. Hypoxia-inducible factor 3 is an oxygen-dependent transcription activator and regulates a distinct transcriptional response to hypoxia.
Zhang P; Yao Q; Lu L; Li Y; Chen PJ; Duan C
Cell Rep; 2014 Mar; 6(6):1110-1121. PubMed ID: 24613356
[TBL] [Abstract][Full Text] [Related]
50. The HIF pathway: implications for patterns of gene expression in cancer.
Wykoff CC; Pugh CW; Harris AL; Maxwell PH; Ratcliffe PJ
Novartis Found Symp; 2001; 240():212-25; discussion 225-31. PubMed ID: 11727931
[TBL] [Abstract][Full Text] [Related]
51. Stabilisation and knockdown of HIF--two distinct ways comparably important in radiotherapy.
Ströfer M; Jelkmann W; Metzen E; Brockmeier U; Dunst J; Depping R
Cell Physiol Biochem; 2011; 28(5):805-12. PubMed ID: 22178933
[TBL] [Abstract][Full Text] [Related]
52. HIF-1 signaling in drug resistance to chemotherapy.
Warfel NA; El-Deiry WS
Curr Med Chem; 2014; 21(26):3021-8. PubMed ID: 24735366
[TBL] [Abstract][Full Text] [Related]
53. Design, synthesis, and structure-activity relationships of 1-ethylpyrazole-3-carboxamide compounds as novel hypoxia-inducible factor (HIF)-1 inhibitors.
Yasuda Y; Arakawa T; Nawata Y; Shimada S; Oishi S; Fujii N; Nishimura S; Hattori A; Kakeya H
Bioorg Med Chem; 2015 Apr; 23(8):1776-87. PubMed ID: 25773014
[TBL] [Abstract][Full Text] [Related]
54. c-Myc is regulated by HIF-2α in chronic hypoxia and influences sensitivity to 5-FU in colon cancer.
Wang L; Xue M; Chung DC
Oncotarget; 2016 Nov; 7(48):78910-78917. PubMed ID: 27793037
[TBL] [Abstract][Full Text] [Related]
55. Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia.
Sowter HM; Raval RR; Moore JW; Ratcliffe PJ; Harris AL
Cancer Res; 2003 Oct; 63(19):6130-4. PubMed ID: 14559790
[TBL] [Abstract][Full Text] [Related]
56. Hypoxia-Inducible Factors (HIFs) in the articular cartilage: a systematic review.
Fernández-Torres J; Zamudio-Cuevas Y; Martínez-Nava GA; López-Reyes AG
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2800-2810. PubMed ID: 28682438
[TBL] [Abstract][Full Text] [Related]
57. Hypoxia Inducible Factors Modify Collagen I Fibers in MDA-MB-231 Triple Negative Breast Cancer Xenografts.
Goggins E; Kakkad S; Mironchik Y; Jacob D; Wildes F; Krishnamachary B; Bhujwalla ZM
Neoplasia; 2018 Feb; 20(2):131-139. PubMed ID: 29247885
[TBL] [Abstract][Full Text] [Related]
58. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
[TBL] [Abstract][Full Text] [Related]
59. [Research progress of hypoxia-inducible factor 1 inhibitors against tumors].
Niu F; Li Y; Lai FF; Chen XG
Yao Xue Xue Bao; 2014 Jun; 49(6):832-6. PubMed ID: 25212028
[TBL] [Abstract][Full Text] [Related]
60. Expression of hypoxia inducible factor 1α and 2α and its association with vitamin C level in thyroid lesions.
Jóźwiak P; Ciesielski P; Zaczek A; Lipińska A; Pomorski L; Wieczorek M; Bryś M; Forma E; Krześlak A
J Biomed Sci; 2017 Oct; 24(1):83. PubMed ID: 29084538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
